Alyeska Investment Group’s Climb Bio, Inc. Common Stock CLYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$602K Buy
+485,364
New +$602K ﹤0.01% 516